<DOC>
	<DOC>NCT00032929</DOC>
	<brief_summary>The purpose of this study is to evaluate the Selegiline Transdermal System for the treatment of cocaine dependence.</brief_summary>
	<brief_title>Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1</brief_title>
	<detailed_description>The study objectives are to assess the efficacy and safety of the Selegiline Transdermal System (STS) in reducing cocaine use in subjects with cocaine dependence. It is hypothesized that selegiline treatment compared to placebo, will be associated with fewer days of cocaine use as assessed by self-report confirmed with urine assays for benzoylecgonine (BE).</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Male/Female At least 18 years of age DSM4 diagnosis of cocaine dependence Ability to understand and provide written consent Female subjects must use acceptable birth control Additional Criteria available during the screening process at the site.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Cocaine Dependence</keyword>
</DOC>